Competing with China, Capping Insulin Costs, & CEOs Speaking to Shareholders 03/01/23
Squawk Pod
00:00
Eli Lilly's Cutting the List Price of Insulin by 70%
Eli Lilly is lowering the list price of its insulin's humalog and humulin by 70% that'll go into effect in the fourth quarter. Meg Terrell: Does this put pressure on Sanofi and Novo Nordisk to bring down prices too? Andrew Ossoak: We don't need to dive into it now, but I'd love to have a look at whether pharmacy benefits managers are good or bad in terms of what they bring to the system.
Play episode from 32:19
Transcript
